Knockdown of MVK does not lead to changes in NALP3 expression or activation

Journal of Inflammation (United Kingdom)

Volumn 12, Issue 1, 2015, Pages

  Celsi, Fulvio ^a   Piscianz, Elisa ^a   Romano, Maurizio ^b   Crovella, Sergio ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Autoimmunity; Immunology; Inflammation; Mevalonate kinase deficiency

Indexed keywords

CRYOPYRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONATE KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE SILENCING; IN VITRO STUDY; MEVALONATE KINASE DEFICIENCY; MOUSE; MVK GENE; NONHUMAN; PROTEIN EXPRESSION;

MURINAE; MUS;

EID: 84924086103     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-015-0048-5     Document Type: Article

References (18)

1. Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debré M, et al. Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med. 2007;356:2700-3. doi:10.1056/NEJMoa070715.
2. Ruiz Gomez A, Couce ML, Garcia-Villoria J, Torres A, Souto A, Yagüe J, et al. Clinical, genetic, and therapeutic diversity in 2 patients with severe mevalonate kinase deficiency. Pediatrics. 2012;129:e535-9. doi:10.1542/peds.2010-2192.
3. Hager EJ, Tse HM, Piganelli JD, Gupta M, Baetscher M, Tse A, et al. Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome. J Inherit Metab Dis. 2007;30:888-95. doi:10.1007/s10545-007-0776-7.
4. Marcuzzi A, Piscianz E, Girardelli M, Crovella S, Pontillo A. Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. Apoptosis. 2011;16:882-8. doi:10.1007/s10495-011-0621-1.
5. Marcuzzi A, Tricarico PM, Piscianz E, Kleiner G, Vecchi Brumatti L, Crovella S. Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line. Cell Death Dis. 2013;4:e585. doi:10.1038/cddis.2013.112.
6. Frenkel J, Rijkers GT, Mandey SHL, Buurman SWM, Houten SM, Wanders RJA, et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum. 2002;46:2794-803.
7. Eisenbarth SC, Flavell RA. Innate instruction of adaptive immunity revisited: The inflammasome. EMBO Mol Med. 2009;1:92-8. doi:10.1002/emmm.200900014.
8. Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M, et al. Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatol Oxf Engl. 2001;40:579-84.
9. Drenth JP, Powell RJ, Brown NS, Van der Meer JW. Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Clin Invest. 1995;25:683-6.
10. Drenth JP, Göertz J, Daha MR, van der Meer JW. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells. Immunology. 1996;88:355-62.
11. Tricarico PM, Marcuzzi A, Piscianz E, Monasta L, Crovella S, Kleiner G. Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis. Int J Mol Sci. 2013;14:23274-88. doi:10.3390/ijms141223274.
12. Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJ, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009;37:e45-5. doi:10.1093/nar/gkp045.
13. Tuomi JM, Voorbraak F, Jones DL, Ruijter JM. Bias in the Cq value observed with hydrolysis probe based quantitative PCR can be corrected with the estimated PCR efficiency value. Methods. 2010;50:313-22. doi:10.1016/j. ymeth.2010.02.003.
14. Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet. 1999;22:175-7. doi:10.1038/9691.
15. Houten SM, Frenkel J, Rijkers GT, Wanders RJA, Kuis W, Waterham HR. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in Hyper-IgD and periodic fever syndrome. Hum Mol Genet. 2002;11:3115-24. doi:10.1093/hmg/11.25.3115.
16. Burgh R van der, Nijhuis L, Pervolaraki K, Compeer EB, Jongeneel LH, van Gijn M et al. Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hyper-secretion. J Biol Chem jbc. 2013;M113.536920. doi:10.1074/jbc.M113.536920.
17. Ghavami S, Sharma P, Yeganeh B, Ojo OO, Jha A, Mutawe MM, et al. Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. Biochim Biophys Acta. 2014;1843(7):1259-71. doi:10.1016/j. bbamcr.2014.03.006.
18. Ghavami S, Yeganeh B, Stelmack GL, Kashani HH, Sharma P, Cunnington R, et al. Apoptosis, autophagy and ER stress in mevalonate cascade inhibitioninduced cell death of human atrial fibroblasts. Cell Death Dis. 2012;21;3:e330. doi:10.1038/cddis.2012.61.